Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone furoate vs fexofenadine for seasonal allergic rhinitis
NCT00502775Phase 4Completed
- Sponsor
- GSK
- Start
- Aug 2007
- Primary completion
- Nov 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluticasone in seasonal allergic rhinitis (SAR) (2 arms), sponsored by GSK. Primary endpoint: Nighttime Symptom Score. Started Aug 2007; status: completed.
02
Drugs
fluticasone
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00502775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00502775.